Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Addresses Complex Clinical Trial Designs In New Guideline

Executive Summary

The advent of precision medicine has prompted sponsors to experiment with complex clinical trial designs, which can involve increased operational complexity. A new EU-wide guidance has been issued on the subject to pave the way for a harmonized approach.

You may also be interested in...



EU Offers Advice On Running Complex Clinical Trials Under CTR

New EU-wide guidance describes the factors that sponsors should consider when designing and conducting trials with complex innovative designs. 

Pharma Will Embrace Basket And Umbrella Trials, Despite Challenges

New approaches in study design and methodology, including master protocol trials, are being adopted by biopharma.

UK Insists No Brexit Impact On Clinical Trial Rates

The UK insists there have been no major changes to the clinical trial environment since the country voted to leave the EU more than three years ago. It says the country continues to be an attractive location for clinical research.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS124902

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel